COVID-19 Law and Policy Briefings, Series One: Drug Development, the Role of the FDA, and Emergency Use
| dc.creator | Sinha, Michael | |
| dc.creator | Zettler, Patricia | |
| dc.date.accessioned | 2022-02-09T16:34:50Z | |
| dc.date.available | 2022-02-09T16:34:50Z | |
| dc.date.issued | 2020-04-15 | |
| dc.identifier.citation | This Week in Health Law, COVID-19 Law and Policy Briefings, Series One: Drug Development, the Role of the FDA, and Emergency Use, (April 15, 2020), https://twihl.podbean.com/mf/play/xwn3cr/twihl_188.mp3. | |
| dc.identifier.uri | http://hdl.handle.net/20.500.12613/7366 | |
| dc.description | The COVID-19 Law and Policy Briefings, hosted in two series from March 2020 through July 2021, feature US and international public health law experts discussing the biggest legal issues arising from the COVID-19 pandemic. The briefings are produced by the George Consortium, co-sponsored by the Center for Health Policy and Law at Northeastern University School of Law, the Center for Public Health Law Research at Temple University Beasley School of Law, and the APHA Law Section. Visit Public Health Law Watch (http://bit.ly/COVIDLawBriefing) to watch episodes. All past briefings are also archived by The Week in Health Law podcast. | |
| dc.description.abstract | This Briefing seeks to demystify drug development — offering a crash in the development process and clinical trials, the role the FDA plays in reviewing and approving drugs, and the differences between off-label and compassionate use. | |
| dc.format.extent | 00:16:32 | |
| dc.language | English | |
| dc.language.iso | eng | |
| dc.relation.ispartof | Center for Public Health Law Research | |
| dc.relation.ispartof | COVID-19 Research | |
| dc.relation.haspart | The Week in Health Law, Ep. 188 | |
| dc.rights | All Rights Reserved | |
| dc.subject | COVID-19 (Disease)--United States | |
| dc.subject | COVID-19 Pandemic, 2020--United States | |
| dc.subject | Public health laws | |
| dc.subject | Vaccines--research | |
| dc.subject | Drug development | |
| dc.relation.youtube | https://www.youtube.com/watch?v=gVWuIWQswFA | |
| dc.title | COVID-19 Law and Policy Briefings, Series One: Drug Development, the Role of the FDA, and Emergency Use | |
| dc.type | Sound | |
| dc.type.genre | Audio recording | |
| dc.contributor.group | George Consortium | |
| dc.contributor.group | Center for Health Policy and Law (Northeastern University School of Law) | |
| dc.contributor.group | Center for Public Health Law Research (Temple University Beasley School of Law) | |
| dc.contributor.group | APHA Law Section | |
| dc.relation.doi | http://dx.doi.org/10.34944/dspace/7344 | |
| dc.ada.note | For Americans with Disabilities Act (ADA) accommodation, including help with reading this content, please contact scholarshare@temple.edu | |
| dc.description.schoolcollege | Temple University. James E. Beasley School of Law | |
| refterms.dateFOA | 2022-02-09T16:34:50Z |